Amy E Schaberg

Title: Amy E Schaberg: Innovator in Cystic Fibrosis Treatment

Introduction

Amy E Schaberg is a notable inventor based in Cary, NC (US). She has made significant contributions to the field of medicine, particularly in the treatment of cystic fibrosis. Her innovative approach has the potential to improve the quality of life for many patients suffering from this condition.

Latest Patents

Amy E Schaberg holds a patent for a method of treating cystic fibrosis. The patent outlines a process that includes identifying a patient suffering from cystic fibrosis and administering an effective amount of denufosol or a pharmaceutically acceptable salt thereof, along with a macrolide. The methods described in the patent allow for the administration of these treatments either by inhalation or orally, providing flexibility in patient care. The pharmaceutical formulation is designed to be in the form of an inhalable dry powder or liquid, with preferred components being denufosol tetrasodium and azithromycin.

Career Highlights

Amy is associated with Inspire Pharmaceuticals, Inc., where she has been instrumental in advancing research and development in respiratory therapies. Her work has led to the creation of innovative treatment options that address the needs of cystic fibrosis patients.

Collaborations

Amy has collaborated with notable colleagues, including Donald J Kellerman and Ramesh Krishnamoorthy. These partnerships have fostered a collaborative environment that enhances the development of effective treatments.

Conclusion

Amy E Schaberg's contributions to the field of cystic fibrosis treatment exemplify the impact of innovation in healthcare. Her patent and work at Inspire Pharmaceuticals, Inc. highlight her commitment to improving patient outcomes through scientific advancements.